Aneel Bhangu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aneel Bhangu has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Dmitri Nepogodiev
University of Birmingham, Birmingham, UK
19 shared publications Dmitri Nepogodiev
Surgical Data Institute, University of Birmingham, Birmingham, UK
9 shared publications- James Glasbey
NIHR Global Health Research Unit on Global Surgery, University of Birmingham, Birmingham, UK
8 shared publications Elizabeth Li
NIHR Global Health Research Unit on Global Surgery, University of Birmingham , Birmingham
7 shared publicationsJames Glasbey
NIHR Global Health Research Unit on Global Surgery, School of Health Sciences, University of Birmingham, Birmingham
7 shared publicationsStephen Tabiri
Ghana Hub, NIHR Global Health Research Unit on Global Surgery, University of Developmental Studies, Tamale, Ghana
7 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Elsevier in The Lancet Global Health
- Vol. 14 (11)
Pre-hospital time and risk of perforation in patients with acute appendicitis in 112 countries (AlliGatOr): an international, prospective, observational cohort study
- 23 September 2026
- Published by Elsevier in The Lancet Global Health
- Vol. 14 (11)
Open AccessPre-hospital time and risk of perforation in patients with acute appendicitis in 112 countries (AlliGatOr): an international, prospective, observational cohort study
- Open Access
- 16 July 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (7) , e022894
Catastrophic health expenditures associated with single admission for paediatric surgery in a low-resource setting: a multicentre study
Background: Catastrophic healthcare expenditure (CHE) poses significant financial burdens on households globally, particularly in low- and middle-income countries. This study was designed to determine the prevalence of CHE among families of paediatric surgical patients admitted for surgery and to explore factors associated with it. Methods: The study was a prospective, multicentre, cross-sectional study carried out in 25 hospitals with paediatric surgery in Nigeria from July to November 2024. Consecutive patients below 16 years of age who underwent surgery were included. CHE was defined as health expenditure above 10% of the head of household annual household income. Data on demographic data, educational and employment status of parents and other related factors were collected and analysed using Stata. Results: A total of 1665 patients were recruited with ages ranging from 5 days to ≤16 years (median=4.74 years). Overall median annual income for the heads of household was US$1097.78. The median (IQR) cost of care was US$129.81 per patient and 56.3% of households spent out of pocket and only 11.7% of households had access to health insurance. A total of 981 households (58.9%; 95% CI 56.5% to 61.3%) experienced CHE. The CHE incidence rate ratio (IRR) decreased among households where the patients were male (IRR 0.92 (95% CI 0.86 to 0.98); p=0.011), the head-of-households had a graduate/postgraduate education (IRR 0.64 (95% CI 0.53 to 0.78); p<0.001), but increased when major surgery was performed (IRR 1.25 (95% CI 1.08 to 1.44); p=0.002) and with prolonged hospital stay (1.008 (95% CI 1.005 to 1.011); p<0.001). The main sources of funds for healthcare were out-of-pocket (n=936, 56.3%) and availability of health insurance was significant in preventing CHE, as three of every four households accessing health insurance did not experience it. Conclusion: Catastrophic health expenditure was highly prevalent among families of children who underwent surgery in Nigeria, particularly among those who had major and emergency surgeries.
- 16 July 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (7) , e022894
Open AccessCatastrophic health expenditures associated with single admission for paediatric surgery in a low-resource setting: a multicentre study
Background: Catastrophic healthcare expenditure (CHE) poses significant financial burdens on households globally, particularly in low- and middle-income countries. This study was designed to determine the prevalence of CHE among families of paediatric surgical patients admitted for surgery and to explore factors associated with it. Methods: The study was a prospective, multicentre, cross-sectional study carried out in 25 hospitals with paediatric surgery in Nigeria from July to November 2024. Consecutive patients below 16 years of age who underwent surgery were included. CHE was defined as health expenditure above 10% of the head of household annual household income. Data on demographic data, educational and employment status of parents and other related factors were collected and analysed using Stata. Results: A total of 1665 patients were recruited with ages ranging from 5 days to ≤16 years (median=4.74 years). Overall median annual income for the heads of household was US$1097.78. The median (IQR) cost of care was US$129.81 per patient and 56.3% of households spent out of pocket and only 11.7% of households had access to health insurance. A total of 981 households (58.9%; 95% CI 56.5% to 61.3%) experienced CHE. The CHE incidence rate ratio (IRR) decreased among households where the patients were male (IRR 0.92 (95% CI 0.86 to 0.98); p=0.011), the head-of-households had a graduate/postgraduate education (IRR 0.64 (95% CI 0.53 to 0.78); p<0.001), but increased when major surgery was performed (IRR 1.25 (95% CI 1.08 to 1.44); p=0.002) and with prolonged hospital stay (1.008 (95% CI 1.005 to 1.011); p<0.001). The main sources of funds for healthcare were out-of-pocket (n=936, 56.3%) and availability of health insurance was significant in preventing CHE, as three of every four households accessing health insurance did not experience it. Conclusion: Catastrophic health expenditure was highly prevalent among families of children who underwent surgery in Nigeria, particularly among those who had major and emergency surgeries.
- Open Access
- 3 July 2026
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 10 (4)
Evaluating quality of colorectal cancer surgery across elective and emergency health systems: secondary analysis of prospective cohort studies in 95 countries
Background: The Lancet Oncology Commission on Global Cancer Surgery recommended that access to and the quality of surgical care be improved. This study aimed to understand differences in surgical quality between emergency and elective resection among patients with potentially curative colorectal cancer. Methods: This preplanned secondary analysis included patients undergoing only curative-intent surgery for colorectal cancer from three contemporary global prospective cohort studies (GlobalSurg-3, 5506 patients; CovidSurg-Cancer, 6719 patients; APOLLO, 876 patients) registered from 2018 to 2023. Hierarchical multilevel logistic regression models quantified associations between the urgency of surgery (elective versus emergency) and surgical quality, measured by margin-positive resection, adjusting for patient, disease, and health system factors. Bootstrap multivariable simulations evaluated effect modification by country income level, cancer stage, and location. Results: Of the 45 699 patients registered, 13 101 across 95 countries were included in this analysis. Overall, 678 patients (5.4%) had margin-positive resections, with higher rates in the emergency than elective surgery group (13.7 versus 4.5%; P < 0.0001). In adjusted multilevel models, emergency surgery was associated with increased odds of margin-positive resections (adjusted odds ratio 2.45, 95% confidence interval (c.i.) 1.86 to 3.22), consistent across all country income groups and robust to alternative health system indicators. Bootstrap-derived absolute risk differences revealed the greatest disparities in patients with stage III–IV rectal cancers, with absolute differences of 12.6% (95% c.i. 10.2 to 15.7) in high-income countries, 19.0% (95% c.i. 13.6 to 23.9) in upper middle-income countries, and 14.1% (95% c.i. 10.9 to 16.5) in lower middle- and low-income countries. Variance decomposition demonstrated that hospital- and country-level factors accounted for 76% of the explained variation in surgical quality. Conclusion: Emergency surgery was associated with a two- to threefold increase in the risk of margin-positive resections globally, independent of resource availability, highlighting a neglected area of global surgical practice. These findings challenge the assumption that poorer outcomes after emergency surgery are due to advanced disease stage. For patients presenting as an emergency with potentially curative resection, enhanced decision-making around resectability, ensuring specialist surgeon availability, and developing bridge-to-surgery pathways represent immediate, low-cost strategies to improve global cancer outcomes.
- 3 July 2026
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 10 (4)
Open AccessEvaluating quality of colorectal cancer surgery across elective and emergency health systems: secondary analysis of prospective cohort studies in 95 countries
Background: The Lancet Oncology Commission on Global Cancer Surgery recommended that access to and the quality of surgical care be improved. This study aimed to understand differences in surgical quality between emergency and elective resection among patients with potentially curative colorectal cancer. Methods: This preplanned secondary analysis included patients undergoing only curative-intent surgery for colorectal cancer from three contemporary global prospective cohort studies (GlobalSurg-3, 5506 patients; CovidSurg-Cancer, 6719 patients; APOLLO, 876 patients) registered from 2018 to 2023. Hierarchical multilevel logistic regression models quantified associations between the urgency of surgery (elective versus emergency) and surgical quality, measured by margin-positive resection, adjusting for patient, disease, and health system factors. Bootstrap multivariable simulations evaluated effect modification by country income level, cancer stage, and location. Results: Of the 45 699 patients registered, 13 101 across 95 countries were included in this analysis. Overall, 678 patients (5.4%) had margin-positive resections, with higher rates in the emergency than elective surgery group (13.7 versus 4.5%; P < 0.0001). In adjusted multilevel models, emergency surgery was associated with increased odds of margin-positive resections (adjusted odds ratio 2.45, 95% confidence interval (c.i.) 1.86 to 3.22), consistent across all country income groups and robust to alternative health system indicators. Bootstrap-derived absolute risk differences revealed the greatest disparities in patients with stage III–IV rectal cancers, with absolute differences of 12.6% (95% c.i. 10.2 to 15.7) in high-income countries, 19.0% (95% c.i. 13.6 to 23.9) in upper middle-income countries, and 14.1% (95% c.i. 10.9 to 16.5) in lower middle- and low-income countries. Variance decomposition demonstrated that hospital- and country-level factors accounted for 76% of the explained variation in surgical quality. Conclusion: Emergency surgery was associated with a two- to threefold increase in the risk of margin-positive resections globally, independent of resource availability, highlighting a neglected area of global surgical practice. These findings challenge the assumption that poorer outcomes after emergency surgery are due to advanced disease stage. For patients presenting as an emergency with potentially curative resection, enhanced decision-making around resectability, ensuring specialist surgeon availability, and developing bridge-to-surgery pathways represent immediate, low-cost strategies to improve global cancer outcomes.
- Open Access
- 18 June 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (6) , e023926
Barriers, facilitators and strategies for implementing on-site hospital solar power in low- and middle-income countries: a systematic review, global prioritisation survey and development of an implementation tool
Introduction: Healthcare facility power-outages in low- and middle-income countries (LMICs) are common and affect patient outcomes. Decentralised solar energy has the potential to reduce power-outages in healthcare settings, yet adoption in LMIC remains modest. This study aimed to identify and prioritise the barriers, facilitators and strategies of on-site healthcare facility solar power implementation. Methods: Methodology was conducted in three phases. In phase 1, a systematic review was completed to summarise barriers and facilitators to implementation of on-site solar power in LMIC healthcare facilities. Any qualitative or mixed-methods study relating to solar power installation from 2009 to 2024 in LMICs was eligible to be included. Barriers and facilitators were extracted from the identified studies and mapped to the Consolidated Framework for Implementation Research. In phase 2, the importance of these barrier and facilitator factors was contextually prioritised through an international survey of healthcare workers on a 5-point Likert scale. In phase 3, strategies were developed from these barrier and facilitator factors to create a solar implementation tool (SOLAR-IT). Results: In phase 1, out of a total of 3678 individual records, 28 studies were included in the systematic review, from which 19 barriers and 29 facilitators were identified. In phase 2, the global survey was completed by 260 participants from 47 LMICs. The barrier with the highest ranked importance was the upfront capital expenditure of solar panel installation, while the most important facilitator was to reduce the cost of solar panels through government intervention. In phase 3, 23 strategies were synthesised within four domains to create the SOLAR-IT. Conclusion: This study describes globally prioritised implementation factors and a strategy tool, which can enable teams to speed up implementation of on-site solar power in a time of extreme global need.
- 18 June 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (6) , e023926
Open AccessBarriers, facilitators and strategies for implementing on-site hospital solar power in low- and middle-income countries: a systematic review, global prioritisation survey and development of an implementation tool
Introduction: Healthcare facility power-outages in low- and middle-income countries (LMICs) are common and affect patient outcomes. Decentralised solar energy has the potential to reduce power-outages in healthcare settings, yet adoption in LMIC remains modest. This study aimed to identify and prioritise the barriers, facilitators and strategies of on-site healthcare facility solar power implementation. Methods: Methodology was conducted in three phases. In phase 1, a systematic review was completed to summarise barriers and facilitators to implementation of on-site solar power in LMIC healthcare facilities. Any qualitative or mixed-methods study relating to solar power installation from 2009 to 2024 in LMICs was eligible to be included. Barriers and facilitators were extracted from the identified studies and mapped to the Consolidated Framework for Implementation Research. In phase 2, the importance of these barrier and facilitator factors was contextually prioritised through an international survey of healthcare workers on a 5-point Likert scale. In phase 3, strategies were developed from these barrier and facilitator factors to create a solar implementation tool (SOLAR-IT). Results: In phase 1, out of a total of 3678 individual records, 28 studies were included in the systematic review, from which 19 barriers and 29 facilitators were identified. In phase 2, the global survey was completed by 260 participants from 47 LMICs. The barrier with the highest ranked importance was the upfront capital expenditure of solar panel installation, while the most important facilitator was to reduce the cost of solar panels through government intervention. In phase 3, 23 strategies were synthesised within four domains to create the SOLAR-IT. Conclusion: This study describes globally prioritised implementation factors and a strategy tool, which can enable teams to speed up implementation of on-site solar power in a time of extreme global need.
- Open Access
- 26 May 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
Feasibility and impact of a large language model pipeline for surgical trial abstracts
S of surgical randomised controlled trials (RCTs) are widely read but often omit key methodological details despite CONSORT guidance. We evaluated whether a tightly constrained large language model (LLM) pipeline could improve completeness and readability at scale. We conducted a three-phase in silico study of consecutive surgical RCTs indexed in PubMed (2005–2025) with open-access full texts in PubMed Central. A 14-item CONSORT-derived rubric (maximum 25 points) was developed and validated against expert scoring, demonstrating good agreement (concordance correlation coefficient 0.71, 95% CI 0.44–0.86) and high reproducibility (intraclass correlation coefficient 0.91, 95% CI 0.80–0.96). An automated pipeline using GPT-4o (OpenAI) generated rewritten abstracts from full texts under strict non-fabrication constraints. Among 651 RCTs, original abstracts showed low completeness (mean 9.06/25, 95% CI 8.58–9.53). Rewriting significantly improved completeness (mean increase 7.40 for 250-word and 8.06 for 300-word versions; both p < 0.0001), with gains across all CONSORT domains, particularly randomisation, harms, and trial registration. Readability improved slightly and correlated with completeness. A constrained LLM pipeline can substantially enhance the completeness of surgical RCT abstracts at scale, with potential applications in authoring, peer review, and editorial workflows, provided appropriate human oversight.
- 26 May 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
Open AccessFeasibility and impact of a large language model pipeline for surgical trial abstracts
S of surgical randomised controlled trials (RCTs) are widely read but often omit key methodological details despite CONSORT guidance. We evaluated whether a tightly constrained large language model (LLM) pipeline could improve completeness and readability at scale. We conducted a three-phase in silico study of consecutive surgical RCTs indexed in PubMed (2005–2025) with open-access full texts in PubMed Central. A 14-item CONSORT-derived rubric (maximum 25 points) was developed and validated against expert scoring, demonstrating good agreement (concordance correlation coefficient 0.71, 95% CI 0.44–0.86) and high reproducibility (intraclass correlation coefficient 0.91, 95% CI 0.80–0.96). An automated pipeline using GPT-4o (OpenAI) generated rewritten abstracts from full texts under strict non-fabrication constraints. Among 651 RCTs, original abstracts showed low completeness (mean 9.06/25, 95% CI 8.58–9.53). Rewriting significantly improved completeness (mean increase 7.40 for 250-word and 8.06 for 300-word versions; both p < 0.0001), with gains across all CONSORT domains, particularly randomisation, harms, and trial registration. Readability improved slightly and correlated with completeness. A constrained LLM pipeline can substantially enhance the completeness of surgical RCT abstracts at scale, with potential applications in authoring, peer review, and editorial workflows, provided appropriate human oversight.
- Open Access
- 18 May 2026
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 113 (6)
Interventions to reduce postoperative mortality in low- and middle-income countries: systematic review
Background: Postoperative mortality is the third leading cause of death worldwide and disproportionately affects patients in low- and middle-income countries (LMICs). Although many deaths are potentially preventable, evidenced-based interventions remain limited. The aim of this systematic review was to consolidate randomized trial evidence on interventions designed to reduce postoperative mortality in LMICs. Methods: Medical databases from database inception to February 2025 were systematically searched for randomized trials evaluating interventions in any aspect of the patient pathway from admission to discharge that were designed to reduce postoperative mortality within 90 days of surgery in LMIC patients. Eligible studies included elective and emergency operations across all surgical specialties. The protocol was preregistered in PROSPERO, the international prospective register of systematic reviews (CRD42024604760). Results: From 10 877 search results, some 18 trials involving 95 521 patients were included. Three were multicountry trials and half were conducted in China. Trials spanned multiple specialties, with only 4 of 18 assessed as having a low risk of bias. Four trials showed a significant reduction in mortality, although the interventions were largely context specific (two neurosurgical trials centred on operative technique in China, one Brazilian trial investigating patient blood management, and one study evaluating maternal death reviews and implementation of best practice after caesarean deliveries in Senegal and Mali). Adherence to interventions was generally high and similar between simple and complex interventions (93.6% versus 96.8% respectively), although adherence varied substantially across trials. Conclusion: Few RCTs have targeted postoperative mortality in LMICs and no intervention demonstrated consistent effectiveness across multiple contexts. To maximize clinical impact, future research should prioritize the development of interventions in regions with the greatest need, particularly sub-Saharan Africa, and ensure they are co-developed with LMIC interest holders and evaluated across diverse clinical environments.
- 18 May 2026
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 113 (6)
Open AccessInterventions to reduce postoperative mortality in low- and middle-income countries: systematic review
Background: Postoperative mortality is the third leading cause of death worldwide and disproportionately affects patients in low- and middle-income countries (LMICs). Although many deaths are potentially preventable, evidenced-based interventions remain limited. The aim of this systematic review was to consolidate randomized trial evidence on interventions designed to reduce postoperative mortality in LMICs. Methods: Medical databases from database inception to February 2025 were systematically searched for randomized trials evaluating interventions in any aspect of the patient pathway from admission to discharge that were designed to reduce postoperative mortality within 90 days of surgery in LMIC patients. Eligible studies included elective and emergency operations across all surgical specialties. The protocol was preregistered in PROSPERO, the international prospective register of systematic reviews (CRD42024604760). Results: From 10 877 search results, some 18 trials involving 95 521 patients were included. Three were multicountry trials and half were conducted in China. Trials spanned multiple specialties, with only 4 of 18 assessed as having a low risk of bias. Four trials showed a significant reduction in mortality, although the interventions were largely context specific (two neurosurgical trials centred on operative technique in China, one Brazilian trial investigating patient blood management, and one study evaluating maternal death reviews and implementation of best practice after caesarean deliveries in Senegal and Mali). Adherence to interventions was generally high and similar between simple and complex interventions (93.6% versus 96.8% respectively), although adherence varied substantially across trials. Conclusion: Few RCTs have targeted postoperative mortality in LMICs and no intervention demonstrated consistent effectiveness across multiple contexts. To maximize clinical impact, future research should prioritize the development of interventions in regions with the greatest need, particularly sub-Saharan Africa, and ensure they are co-developed with LMIC interest holders and evaluated across diverse clinical environments.
- Top Cited PapersOpen Access
- 4 March 2026
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 113 (3)
Systematic review of the Lancet Commission on Global Surgery indicators with quality assessment of modelled estimates
Background: The Lancet Commission on Global Surgery (LCoGS) defined six indicators with 2030 targets to track national surgical system performance. The aim of this systematic review was to evaluate national reporting and attainment of benchmarks for each indicator and to assess the quality of modelling studies used to fill data gaps. Methods: Seven bibliographic databases (1 April 2015–24 July 2024) and government domains of 48 countries committed to National Surgical, Obstetric, and Anaesthesia Plans were searched. Records providing national estimates of any LCoGS indicator were eligible. The primary outcome was the proportion of World Bank-classified countries meeting indicator benchmarks and the secondary outcome was the quality of modelled national estimates. This systematic review was prospectively registered in PROSPERO, the international prospective register of systematic reviews (CRD420250650890). Results: Of 4245 records retrieved, 44 studies were included (35 research articles and 9 policy documents). Among 217 World Bank-classified countries, access to timely essential surgery (indicator 1) was reported for 94 countries (39% meeting benchmark), specialist surgical workforce density (indicator 2) was reported for 167 countries (50.3% meeting benchmark), surgical volume (indicator 3) was reported for 124 countries (31.5% meeting benchmark), perioperative mortality (indicator 4) was reported for 74 countries (no benchmark was set at country level), and financial risk protection indicators (indicators 5 and 6) were reported for five countries, with none meeting either benchmark. Across indicators, high-income countries were more likely to meet benchmarks. Most modelled studies lacked transparency in data sources, statistical methods, or model validation. Conclusion: Reporting of LCoGS indicators remains sparse and uneven, particularly in low- and middle-income countries. Without standardized, routine measurement and minimum quality standards for modelled estimates, progress towards 2030 cannot be credibly tracked. Integrating surgical metrics into national health information systems should be a policy priority.
- 4 March 2026
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 113 (3)
Top Cited PapersOpen AccessSystematic review of the Lancet Commission on Global Surgery indicators with quality assessment of modelled estimates
Background: The Lancet Commission on Global Surgery (LCoGS) defined six indicators with 2030 targets to track national surgical system performance. The aim of this systematic review was to evaluate national reporting and attainment of benchmarks for each indicator and to assess the quality of modelling studies used to fill data gaps. Methods: Seven bibliographic databases (1 April 2015–24 July 2024) and government domains of 48 countries committed to National Surgical, Obstetric, and Anaesthesia Plans were searched. Records providing national estimates of any LCoGS indicator were eligible. The primary outcome was the proportion of World Bank-classified countries meeting indicator benchmarks and the secondary outcome was the quality of modelled national estimates. This systematic review was prospectively registered in PROSPERO, the international prospective register of systematic reviews (CRD420250650890). Results: Of 4245 records retrieved, 44 studies were included (35 research articles and 9 policy documents). Among 217 World Bank-classified countries, access to timely essential surgery (indicator 1) was reported for 94 countries (39% meeting benchmark), specialist surgical workforce density (indicator 2) was reported for 167 countries (50.3% meeting benchmark), surgical volume (indicator 3) was reported for 124 countries (31.5% meeting benchmark), perioperative mortality (indicator 4) was reported for 74 countries (no benchmark was set at country level), and financial risk protection indicators (indicators 5 and 6) were reported for five countries, with none meeting either benchmark. Across indicators, high-income countries were more likely to meet benchmarks. Most modelled studies lacked transparency in data sources, statistical methods, or model validation. Conclusion: Reporting of LCoGS indicators remains sparse and uneven, particularly in low- and middle-income countries. Without standardized, routine measurement and minimum quality standards for modelled estimates, progress towards 2030 cannot be credibly tracked. Integrating surgical metrics into national health information systems should be a policy priority.
- Open Access
- 31 January 2026
- Published by Impact Health in Impact Surgery
- Vol. 3 (1) , 334-335
2025: a year in summary, and expectations for 2026
2025 was a year of both consolidation and expansion for the Impact Health Publishing Group (https://impact-journals.org). Alongside continued growth of our flagship Impact Surgery, we launched Impact Case Reports and Impact Public Health, extending the group’s scope across clinical outcomes, systems, and implementation research. Looking ahead to 2026, the group will embark on the journey of formal registrations with the Directory of Open Access Journals (DOAJ) and PubMed Central. These steps are essential for long-term credibility and visibility, but they also carry substantial operational costs. As a result, and in the interest of transparency, we anticipate the introduction of an author publication charge at that stage, complemented by ethical sponsorship and advertising. Our commitment is to deliver what we describe as the “EasyJet experience” for authors: a reliable, efficient, and professional publishing process, at a lower cost than premium journals, without compromising editorial standards or integrity.
- 31 January 2026
- Published by Impact Health in Impact Surgery
- Vol. 3 (1) , 334-335
Open Access2025: a year in summary, and expectations for 2026
2025 was a year of both consolidation and expansion for the Impact Health Publishing Group (https://impact-journals.org). Alongside continued growth of our flagship Impact Surgery, we launched Impact Case Reports and Impact Public Health, extending the group’s scope across clinical outcomes, systems, and implementation research. Looking ahead to 2026, the group will embark on the journey of formal registrations with the Directory of Open Access Journals (DOAJ) and PubMed Central. These steps are essential for long-term credibility and visibility, but they also carry substantial operational costs. As a result, and in the interest of transparency, we anticipate the introduction of an author publication charge at that stage, complemented by ethical sponsorship and advertising. Our commitment is to deliver what we describe as the “EasyJet experience” for authors: a reliable, efficient, and professional publishing process, at a lower cost than premium journals, without compromising editorial standards or integrity.
- Open Access
- 31 January 2026
- Published by Impact Health in Impact Surgery
- Vol. 3 (1) , 338-348
Staged meta-analysis of high- versus low-quality randomised trials testing triclosan coated sutures on surgical site infection after abdominal surgery
Introduction: Conflicting meta-analyses have been published comparing the effectiveness of triclosan coated sutures. This creates confusion amongst clinical teams, guideline committees, and policymakers for how to interpret these findings. We aimed to understand how study quality influences the results of meta-analysis on the use of triclosan sutures in patients undergoing abdominal surgery and impact on surgical site infection. Methods: A systematic review was performed to identify randomised controlled trials comparing triclosan coated versus uncoated sutures for closure of the fascial layer during clean-contaminated, contaminated, and dirty abdominal surgery, published up to April 2024. We performed a sequence of pre-specified meta-analyses, to understand the effects of including low quality studies and explore potential sources of bias. We then performed a simulated meta-analysis to determine the effect of new randomised trials being added to the high quality evidence base. Results: From 634 studies, our final meta-analysis included 15 studies (n=11,475 patients), of which six were high quality and nine low quality studies. The high quality studies included 8,937 patients from 12 countries. The low quality included 2,538 from 11 countries. The high quality studies showed no significant difference in rates of surgical site infections (OR: 0.88, 95% CI: 0.71 - 1.09). When the low quality studies were included, there was a significant shift in the effect to show a benefit with triclosan-coated sutures (OR: 0.67, 95% CI: 0.54 - 0.83). Meta-regression identified that increasing study quality was associated with smaller effect size towards non-significance. Simulation showed that new studies will only marginally shift these results and only if strongly positive. Conclusion: This study highlights potential uncertainty around the clinical effectiveness of triclosan-coated sutures, particularly when assessed through high-quality randomised trials. While lower-quality studies suggest benefit, these effects were not replicated in more robust evidence, although geographical uncertainty and practices in different settings around the world may explain some differences. However, some caution may be needed in value-based health systems, especially if prices fluctuate, and such investment may be best suited to high-risk or expensive cases where marginal gains are important. As clinical practice continues to evolve, further well-conducted, high-quality trials (including both randomised and efficient platform observational cohort studies) may help resolve this uncertainty.
- 31 January 2026
- Published by Impact Health in Impact Surgery
- Vol. 3 (1) , 338-348
Open AccessStaged meta-analysis of high- versus low-quality randomised trials testing triclosan coated sutures on surgical site infection after abdominal surgery
Introduction: Conflicting meta-analyses have been published comparing the effectiveness of triclosan coated sutures. This creates confusion amongst clinical teams, guideline committees, and policymakers for how to interpret these findings. We aimed to understand how study quality influences the results of meta-analysis on the use of triclosan sutures in patients undergoing abdominal surgery and impact on surgical site infection. Methods: A systematic review was performed to identify randomised controlled trials comparing triclosan coated versus uncoated sutures for closure of the fascial layer during clean-contaminated, contaminated, and dirty abdominal surgery, published up to April 2024. We performed a sequence of pre-specified meta-analyses, to understand the effects of including low quality studies and explore potential sources of bias. We then performed a simulated meta-analysis to determine the effect of new randomised trials being added to the high quality evidence base. Results: From 634 studies, our final meta-analysis included 15 studies (n=11,475 patients), of which six were high quality and nine low quality studies. The high quality studies included 8,937 patients from 12 countries. The low quality included 2,538 from 11 countries. The high quality studies showed no significant difference in rates of surgical site infections (OR: 0.88, 95% CI: 0.71 - 1.09). When the low quality studies were included, there was a significant shift in the effect to show a benefit with triclosan-coated sutures (OR: 0.67, 95% CI: 0.54 - 0.83). Meta-regression identified that increasing study quality was associated with smaller effect size towards non-significance. Simulation showed that new studies will only marginally shift these results and only if strongly positive. Conclusion: This study highlights potential uncertainty around the clinical effectiveness of triclosan-coated sutures, particularly when assessed through high-quality randomised trials. While lower-quality studies suggest benefit, these effects were not replicated in more robust evidence, although geographical uncertainty and practices in different settings around the world may explain some differences. However, some caution may be needed in value-based health systems, especially if prices fluctuate, and such investment may be best suited to high-risk or expensive cases where marginal gains are important. As clinical practice continues to evolve, further well-conducted, high-quality trials (including both randomised and efficient platform observational cohort studies) may help resolve this uncertainty.
- Open Access
- 30 November 2025
- Published by Impact Health in Impact Surgery
- Vol. 2 (7) , 278-291
Scaling robotic surgery in the NHS: National expenditure projections and adaptive budget-impact scenarios for soft-tissue platforms
Background Robot-assisted soft-tissue surgery is expanding in the NHS. Policymakers need estimates of the public cash required to scale access, both in gross terms and net after accouting for existing laparoscopy costs. Methods We built ten-year, England-wide, payer-perspective budget-impact models using 2023/24 surgical activity. Multiple platforms were simulated and grouped by capability and cost (A premium, B mid-tier, C low-cost hybrid). Nine scenarios crossed three adoption targets (30%, 50%, 90% robotic by Year 5) with three deployment mixes (Full A; Mixed A+B; Hybrid A+B for major, C for high-throughput lists). Capital was spread across Years 1-5; replacement was 4%/year in Years 6-10; consumables ramped to steady state by Year 5. The primary analysis was cash total without discounting (national expenditure projection) and a prespecified sensitivity analysis offset existing laparoscopic costs (budget impact scenario), taking into account a 20% open to robotic conversion rate. A pay-per-use (PPU) variant was explored for 90% adoption. Results Gross programme spend rose during implementation and then stabilised as replacement dominated. At Year 5, gross spend was 0.03% (30% Hybrid), 0.14% (50% Mixed), and 0.29% (90% Full) of the NHS budget, settling by Year 10 at 0.02%, 0.09%, and 0.18%. In the budget-impact sensitivity model, displaced laparoscopy costs offset 18-45% of the robotic spend depending on scenario, yielding a lower net investment that peaks at Year 5 and settles to 0.02-0.17% of the NHS budget by Year 10. At that point, annual gross versus net spend were £0.05bn vs £0.03bn for 30% Hybrid, £0.33bn vs £0.16bn for 50% Mixed, and £0.93bn vs £0.33bn for 90% Full. PPU smoothed annual outlay at 90% adoption but did not materially change the ten-year totals. If each robotic system achieves a throughput at 350 cases per year, overall programme cost reduce by approximately 8% across scenarios. Interpretation: Robotic expansion in the NHS appears affordable if utilisation is managed, with existing laparoscopy offsetting a meaningful share of the required spend. Flexible contracting (e.g. subscription based models) can smooth early spending without altering long-run totals. Roll-out should proceed alongside a ten-year programme of clinical outcome research to confirm cost-effectiveness and refine investment over time.
- 30 November 2025
- Published by Impact Health in Impact Surgery
- Vol. 2 (7) , 278-291
Open AccessScaling robotic surgery in the NHS: National expenditure projections and adaptive budget-impact scenarios for soft-tissue platforms
Background Robot-assisted soft-tissue surgery is expanding in the NHS. Policymakers need estimates of the public cash required to scale access, both in gross terms and net after accouting for existing laparoscopy costs. Methods We built ten-year, England-wide, payer-perspective budget-impact models using 2023/24 surgical activity. Multiple platforms were simulated and grouped by capability and cost (A premium, B mid-tier, C low-cost hybrid). Nine scenarios crossed three adoption targets (30%, 50%, 90% robotic by Year 5) with three deployment mixes (Full A; Mixed A+B; Hybrid A+B for major, C for high-throughput lists). Capital was spread across Years 1-5; replacement was 4%/year in Years 6-10; consumables ramped to steady state by Year 5. The primary analysis was cash total without discounting (national expenditure projection) and a prespecified sensitivity analysis offset existing laparoscopic costs (budget impact scenario), taking into account a 20% open to robotic conversion rate. A pay-per-use (PPU) variant was explored for 90% adoption. Results Gross programme spend rose during implementation and then stabilised as replacement dominated. At Year 5, gross spend was 0.03% (30% Hybrid), 0.14% (50% Mixed), and 0.29% (90% Full) of the NHS budget, settling by Year 10 at 0.02%, 0.09%, and 0.18%. In the budget-impact sensitivity model, displaced laparoscopy costs offset 18-45% of the robotic spend depending on scenario, yielding a lower net investment that peaks at Year 5 and settles to 0.02-0.17% of the NHS budget by Year 10. At that point, annual gross versus net spend were £0.05bn vs £0.03bn for 30% Hybrid, £0.33bn vs £0.16bn for 50% Mixed, and £0.93bn vs £0.33bn for 90% Full. PPU smoothed annual outlay at 90% adoption but did not materially change the ten-year totals. If each robotic system achieves a throughput at 350 cases per year, overall programme cost reduce by approximately 8% across scenarios. Interpretation: Robotic expansion in the NHS appears affordable if utilisation is managed, with existing laparoscopy offsetting a meaningful share of the required spend. Flexible contracting (e.g. subscription based models) can smooth early spending without altering long-run totals. Roll-out should proceed alongside a ten-year programme of clinical outcome research to confirm cost-effectiveness and refine investment over time.